SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-09-014680
Filing Date
2009-06-17
Accepted
2009-06-17 15:45:20
Documents
3
Period of Report
2009-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OXIGENE, INC. b75880oie8vk.htm 8-K 19180
2 EX-10.1 EMPLOYMENT AGREEMENT BY AND AMONG OXIGENE AND DR. PETER LANGECKER, DATED b75880oiexv10w1.htm EX-10.1 58123
3 EX-99.1 PRESS RELEASE DATED JUNE 17, 2009. b75880oiexv99w1.htm EX-99.1 10182
  Complete submission text file 0000950123-09-014680.txt   89172
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 09896583
SIC: 2836 Biological Products, (No Diagnostic Substances)